Advanced cardiopulmonary care technologies, such as ventricular assist devices and extracorporeal membrane oxygenation, suggest the importance of considering whether, when, and for how long they should be used. These life-sustaining therapies can postpone certain death, reshape our views about what should be considered good end-of-life care, and prompt examination of what clinicians’ roles might be in patients’ experiences of death.